William P Sheridan - Net Worth and Insider Trading
William P Sheridan Net Worth
The estimated net worth of William P Sheridan is at least $307,807 dollars as of 2024-09-21. William P Sheridan is the Chief Medical Officer of BioCryst Pharmaceuticals Inc and owns about 37,954 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $307,807. Details can be seen in William P Sheridan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William P Sheridan has not made any transactions after 2022-03-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William P Sheridan
William P Sheridan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William P Sheridan owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of William P Sheridan’s form 4 insider trades.
Insider Ownership Summary of William P Sheridan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2022-03-10 | SR VP - CMO |
William P Sheridan Latest Holdings Summary
William P Sheridan currently owns a total of 1 stock. William P Sheridan owns 37,954 shares of BioCryst Pharmaceuticals Inc (BCRX) as of March 10, 2022, with a value of $307,807.
Latest Holdings of William P Sheridan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2022-03-10 | 37,954 | 8.11 | 307,807 |
Holding Weightings of William P Sheridan
William P Sheridan Form 4 Trading Tracker
According to the SEC Form 4 filings, William P Sheridan has made a total of 2 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 161,139 shares on March 10, 2022, which brought William P Sheridan around $3 Million.
Insider Trading History of William P Sheridan
- 1
William P Sheridan Trading Performance
GuruFocus tracks the stock performance after each of William P Sheridan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William P Sheridan is 108.42%. GuruFocus also compares William P Sheridan's trading performance to market benchmark return within the same time period. The performance of stocks bought by William P Sheridan within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William P Sheridan's insider trading performs compared to the benchmark.
Performance of William P Sheridan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -36.84 | | | | | |
| Relative Return to S&P 500(%) | -21.7 | | | | | |
William P Sheridan Ownership Network
William P Sheridan Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
William P Sheridan is the SR VP - CMO of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, William P Sheridan made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net purchase of 23,000 shares made by Helen M. Thackray , a net sale of 8,689 shares made by Machelle Sanders , and a net sale of 7,866 shares made by Nancy J Hutson .
In summary, during the past 3 months, insiders sold 8,600 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 8,600 shares. During the past 18 months, 43,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 139,748 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
William P Sheridan Mailing Address
Above is the net worth, insider trading, and ownership report for William P Sheridan. You might contact William P Sheridan via mailing address: 2190 Parkway Lake Dr, Birmingham Al 35244.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
